Predicting Occlusion Myocardial Infarctions in the Emergency Department Using Artificial Intelligence

利用人工智能预测急诊科发生的闭塞性心肌梗死

阅读:1

Abstract

OBJECTIVES: The objective was to develop an artificial intelligence (AI) model for predicting acute coronary occlusion myocardial infarction (OMI) in patients with chest pain at the emergency department (ED), using information that is widely available early in the ED assessment. METHODS: In a cohort of 24,511 consecutive adult ED patients with chest pain from 5 Swedish hospitals, OMI cases were identified through register data and manual review of health records and angiographies. Ambulance patients bypassing the ED due to ST-elevation myocardial infarction (STEMI) were not included in the cohort. A deep-learning AI model was created to predict OMI using the electrocardiogram, optionally combined with other early ED data, including medical history and initial lab values. The model was internally validated on held-out data and compared with the STEMI criteria. RESULTS: A total of 467 patients (1.9%) were identified as OMI, corresponding to 29% of all acute myocardial infarction cases. The 30-day mortality rate was 6.6% for OMI, compared with 3.3% for non-OMI. Only 5.4% of the OMI cases received angiography within the guideline-recommended maximum of 90 minutes after ED arrival. The AI model achieved an area under the receiver operating characteristic (AUC) of 95.3% (95% CI, 93.8%-97.3%), with a sensitivity of 62% compared with 27% for the STEMI criteria (difference 34.5%; 95% CI, 22.9%-45.2%) at the same specificity (97.4%). CONCLUSION: Our AI model identified OMI in ED patients with chest pain with an AUC of 95%, doubling sensitivity compared with the STEMI criteria at the same specificity. Using the model could reduce time to intervention, as only about 1 in 20 OMI cases currently receive timely angiography.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。